Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors

Hepatocellular carcinoma (HCC) is a leading cause of mortality. Checkpoint inhibitors of programmed cell death protein‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) have shown great efficacy, but lack biomarkers that predict response. Circulating tumor cells (CTCs) have promise as a liquid‐biopsy b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepatol Commun
Main Authors: Winograd, Paul, Hou, Shuang, Court, Colin M., Lee, Yi‐Te, Chen, Pin‐Jung, Zhu, Yazhen, Sadeghi, Saeed, Finn, Richard S., Teng, Pai‐Chi, Wang, Jasmin J., Zhang, Zhicheng, Liu, Hongtao, Busuttil, Ronald W., Tomlinson, James S, Tseng, Hsian‐Rong, Agopian, Vatche G.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527695/
https://ncbi.nlm.nih.gov/pubmed/33024921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1577
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados